SARTORIS, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 6.014
EU - Europa 4.979
AS - Asia 3.188
SA - Sud America 551
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 83
OC - Oceania 10
Totale 14.994
Nazione #
US - Stati Uniti d'America 5.820
RU - Federazione Russa 1.616
GB - Regno Unito 1.215
SG - Singapore 1.204
CN - Cina 1.011
IT - Italia 524
BR - Brasile 418
DE - Germania 417
VN - Vietnam 283
FI - Finlandia 278
HK - Hong Kong 246
SE - Svezia 231
FR - Francia 223
IE - Irlanda 192
CA - Canada 97
KR - Corea 86
UA - Ucraina 79
BD - Bangladesh 70
IN - India 46
TR - Turchia 46
AR - Argentina 45
NL - Olanda 43
ID - Indonesia 38
JP - Giappone 33
PL - Polonia 31
MX - Messico 28
ZA - Sudafrica 28
ES - Italia 27
BE - Belgio 26
IQ - Iraq 22
NG - Nigeria 21
PK - Pakistan 21
VE - Venezuela 20
CO - Colombia 19
EC - Ecuador 17
AT - Austria 13
CR - Costa Rica 12
PY - Paraguay 11
SA - Arabia Saudita 11
AU - Australia 10
IR - Iran 10
TT - Trinidad e Tobago 10
CL - Cile 8
CW - ???statistics.table.value.countryCode.CW??? 8
HN - Honduras 8
IL - Israele 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
JO - Giordania 7
NI - Nicaragua 7
GT - Guatemala 6
LV - Lettonia 6
PE - Perù 6
UZ - Uzbekistan 6
CH - Svizzera 5
EG - Egitto 5
LU - Lussemburgo 5
MY - Malesia 5
RO - Romania 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DK - Danimarca 4
EU - Europa 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
PA - Panama 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BJ - Benin 3
ET - Etiopia 3
GP - Guadalupe 3
KE - Kenya 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
SV - El Salvador 3
TG - Togo 3
AG - Antigua e Barbuda 2
AM - Armenia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
Totale 14.817
Città #
Southend 1.027
Ashburn 906
Singapore 641
Moscow 565
Jacksonville 502
San Jose 477
Chandler 446
Dallas 437
Woodbridge 387
Verona 274
Hong Kong 243
Ann Arbor 236
Dublin 185
Munich 167
Council Bluffs 154
Beijing 153
The Dalles 140
New York 138
Los Angeles 120
Houston 118
Helsinki 99
Jinan 80
Nanjing 79
Wilmington 78
Ho Chi Minh City 75
Princeton 74
Lawrence 73
Shenyang 73
Hanoi 58
Buffalo 53
Santa Clara 51
Tianjin 48
Turku 48
São Paulo 47
Hebei 45
Haikou 41
Zhengzhou 39
Columbus 36
Milan 35
Nanchang 32
Orem 32
Changsha 27
Dong Ket 27
Hangzhou 27
Montreal 27
Brussels 26
Boardman 25
Sindelfingen 25
Toronto 25
Atlanta 24
Ningbo 24
London 23
Redmond 23
Tokyo 23
Jakarta 22
Johannesburg 22
Taiyuan 22
Denver 21
Las Vegas 21
Redwood City 21
Abuja 20
Guangzhou 20
Warsaw 20
Amsterdam 19
Chicago 19
Frankfurt am Main 19
Taizhou 19
Seoul 17
Stockholm 17
Brooklyn 16
Seattle 16
Chennai 15
Da Nang 14
Düsseldorf 14
Rome 14
Cambridge 13
Manchester 13
Nürnberg 13
Jiaxing 12
Lancaster 12
San Francisco 12
Ankara 11
Belo Horizonte 11
Fairfield 11
Falls Church 11
Lanzhou 11
Phoenix 11
Annandale 10
Fuzhou 10
Madrid 10
Naples 10
North Bergen 10
Norwalk 10
Philadelphia 10
Poplar 10
Redondo Beach 10
Caracas 9
City of London 9
Curitiba 9
Detroit 9
Totale 9.493
Nome #
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 347
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 332
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 320
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 319
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 303
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 298
Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. 281
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 278
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 269
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 268
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 261
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 256
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 256
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 251
Autologous cellular vaccine allows control of cancer immunoediting in a mouse model of plasmacytoma. 249
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 248
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 246
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 244
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 238
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 232
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability 226
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 220
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. 217
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 211
A non-parametric method for the analysis of experimental tumour growth data 207
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 207
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. 206
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 203
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 199
Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites 193
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 193
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 189
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. 186
A rapid and improved method for generating cDNA libraries in plasmid and phage lambda vectors 183
Distinct regulation of HLA class II and class I cell surface expression in the THP-1 macrophage cell line after bacterial phagocytosis 182
A rapid and improved method for generating cDNA libraries in plasmid and phage vectors 182
Immune regulation by Mesenchymal Stem Cells derived from adult spleen and thymus. 181
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 180
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITa trans-activator 178
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of Major Histocompatibility Complex class II gene expression observed during differentiation from B cells to plasma cells. 178
Local ablation disrupts immune evasion in pancreatic cancer 175
The Endless Saga of Monocyte Diversity 173
CONSTITUTIVE AND INDUCIBLE EXPRESSION OF HLA CLASS II GENES IN NORMAL CELLS UNDER THE CONTROL OF THE AIR-1-ENCODED CIITA TRANS-ACTIVATOR 172
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 172
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. 171
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 170
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 166
Mitochondrial DNA polymorphism analyzed by restriction endonucleases in two sardinian populations 163
The Engagement Between MDSCs and Metastases: Partners in Crime 162
Structure and regulation of MHC system 161
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 159
Expression of HLA antigens in human pancreatic carcinomas 159
Functional significance of polymorphism among MHC class II gene promoters. 153
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 149
Divergent evolution in the mechanisms controlling MHC class II gene transcription in mouse and human. 147
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 147
HLA-DBQ1 typing of north east italian IDDM patients using amplified DNA oligonucleotide probes and a rapid DNA-enzyme immunoassay(DEIA). 145
SEQUENCE POLYMORPHISM OF HLA-DP b CHAINS 144
Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum 141
Evidence for a specific post-transcriptional mechanisms controlling the expression of HLA-DQ, but not -DR and -DP, molecules. 140
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 137
Polimorfismo genetico mitocondriale in popolazioni sarde esposte a differente pressione selettiva malarica 137
Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes 137
Regulation of CD5 gene expression in interspecies human x mouse T cell hybrids 136
Organization, polymorphism and regulation of class II genes of the major histocompatibility complex. 134
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 133
Mitochondrial DNA polymorphism in four Sardinian villages 131
Transcriptional regulation of MHC class II genes 130
HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA) 127
Moonlighting Proteins Are Important Players in Cancer Immunology 126
Oscillating growth patterns of multicellular tumour spheroids 125
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. 124
MHC: AN INTEGRATED GENETIC SYSTEM WHICH ORCHESTRATES THE IMMUNE RESPONSE. 123
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 123
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 122
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle 117
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules 112
Exploring the HLA complex in autoimmunity: from the risk haplotypes to the modulation of expression 103
MHC: orchestrating the immune response 86
null 33
Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies 12
Totale 14.994
Categoria #
all - tutte 47.517
article - articoli 36.309
book - libri 0
conference - conferenze 9.705
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.503
Totale 95.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022403 0 0 0 33 26 18 30 41 37 28 59 131
2022/20231.301 87 151 134 231 122 278 11 82 147 7 26 25
2023/2024634 13 42 45 101 62 108 29 48 2 40 94 50
2024/20252.024 91 111 75 270 101 85 161 132 327 105 180 386
2025/20265.573 372 351 393 965 1.390 340 530 282 421 325 122 82
2026/20271.089 59 147 245 638 0 0 0 0 0 0 0 0
Totale 14.994